From Phase 1 human trials for a Malaria vaccine, to studies aimed at treating osteoporosis and research into life-saving stroke treatment, the Gold Coast Health & Knowledge Precinct is fast gaining a reputation as a leading location for clinical trials.
The trial of a malaria vaccine developed by Griffith University’s Institute for Glycomics’ Professor Michael Good could potentially save millions of lives and is the most well-known study to date, but a variety of trials occurring across both the Gold Coast University Hospital (GCUH) and the university offer the promise of exciting innovations targeting a diversity of diseases and health conditions.
The Gold Coast community benefits with patient access to the latest treatments.
Within the advanced tertiary hospital setting of Gold Coast University Hospital, trials occur across a range of specialities, involving inpatients and outpatients.
Neurologist Dr Arman Sabet has been involved in ten clinical trials, with a primary focus on improving treatment for stroke
Skip to content
News and other stories about real people, places, and events in Mount Gravatt and nearby suburbs.